Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Chemical Biology & Drug Design|August 3, 2006
Synthesis and pharmacological activity of 2-(substituted)-3-{2-[(4-phenyl-4-cyano)piperidino]ethyl}-1,3-thiazolidin-4-onesOrazio Mazzoni, Antonio Mazzella di Bosco, Paolo Grieco, et al.
Progress in Neurobiology|December 6, 2016
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectivesDaniela Giuliani, Alessandra Ottani, Laura Neri, et al.
Pulmonary Pharmacology & Therapeutics|November 11, 2008
A role for MC3R in modulating lung inflammationStephen J Getting, Yanira Riffo-Vasquez, Simon Pitchford, et al.
Veterinary Sciences|January 28, 2026
Antimicrobial Activity of Bioactive Peptides on Resistant Enterobacteriaceae and the Viability of Giardia duodenalis Cysts Isolated from Healthy DogsAntonio Santaniello, Emanuela Roscetto, Umberto Galdiero, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 22, 2011
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1TaPaolo Grieco, Vincenzo Luca, Luigia Auriemma, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 20, 2015
An investigation into the origin of the biased agonism associated with the urotensin II receptor activationDiego Brancaccio, Francesco Merlino, Antonio Limatola, et al.
Molecules (Basel, Switzerland)|January 24, 2019
Rationally Designed α-Conotoxin Analogues Maintained Analgesia Activity and Weakened Side EffectsChen Liu, Pengxiang Wu, He Zhu, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 18, 2019
Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cellsAndrea Caporale, Aaron D Martin, Dominga Capasso, et al.
Journal of Medicinal Chemistry|May 31, 2002
Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptorsMalcolm J Kavarana, Dev Trivedi, Minying Cai, et al.
Pageof 16